COMBINING A NOVEL DUAL RAF/MEK INHIBITOR WITH IMMUNOMODULATION TO PROMOTE AN ANTI-TUMOR RESPONSE

被引：0

作者：

Dong, Lauren ^{[1
]}

Choi, Hyejin ^{[1
]}

Budhu, Sadna ^{[1
]}

Schulze, Isabell ^{[1
]}

Mehanna, Nezar ^{[1
]}

Rosen, Neal ^{[1
]}

Merghoub, Taha ^{[1
]}

Wolchok, Jedd ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷

关键词：

D O I：

10.1136/jitc-2021-SITC2021.604

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

604

引用

页码：A634 / A634

页数：1

共 50 条

[21] IK-595, a MEK-RAF complex inhibitor, obviates CRAF mediated resistance resulting in superior RAS/MAPK pathway inhibition and anti-tumor activity in RAS/RAF altered cancers
Haines, Eric
Burke, Michael
Catterall, Rachel
De Jesus, Victor
Li, Bin
Manna, Joseph D.
Punkosdy, George
Zavidij, Oksana
Wessel, Sarah R.
Werosta, Grace
Cavanaugh, Jill
Newhouse, Sheila
Basavapathruni, Aravind
Xu, Lan
Santillana, Sergio
Zhang, Michelle
Ruppel, Sabine K.
MOLECULAR CANCER RESEARCH, 2023, 21 (05)
[22] Anti-tumor immunotherapeutic strategy for uveal melanoma by combining photodynamic therapy with ROCK inhibitor
Kim, Seohyun
Kim, In-San
CANCER RESEARCH, 2020, 80 (16)
[23] RETRACTED: A Novel Copper Chelate Modulates Tumor Associated Macrophages to Promote Anti-Tumor Response of T Cells (Retracted Article)
Chatterjee, Shilpak
Mookerjee, Ananda
Basu, Jayati Mookerjee
Chakraborty, Paramita
Ganguly, Avishek
Adhikary, Arghya
Mukhopadhyay, Debanjan
Ganguli, Sudipta
Banerjee, Rajdeep
Ashraf, Mohammad
Biswas, Jaydip
Das, Pradeep K.
Sa, Gourisankar
Chatterjee, Mitali
Das, Tanya
Choudhuri, Soumitra Kumar
PLOS ONE, 2009, 4 (09):
[24] Pharmacological profile and anti-tumor properties of LXH254, a highly selective RAF kinase inhibitor
Stuart, Darrin D.
Shao, Wenlin
Mishina, Yuji
Feng, Yun
Caponigro, Giordano
Cooke, Vesselina G.
Rivera, Stacey
Shen, Fang
Korn, Joshua
Griner, Lesley A. Mathews
Nishiguchi, Giselle
Taft, Benjamin
Wan, Lifeng
Subramanian, Sharadha
Lou, Yan
Setti, Lina
Burger, Matthew
Tamez, Victor
Rico, Alice
Aversa, Robert
Tellew, John
Haling, Jacob R.
Polyakov, Valery
Lambert, Amy
Zang, Richard
Van Abbema, Ann
Hekmat-Nejad, Mohamad
Amiri, Payman
Singh, Mallika
Keen, Nicholas
Dillon, Michael P.
Lees, Emma
Sellers, William R.
Ramurthy, Savithri
CANCER RESEARCH, 2018, 78 (13)
[25] Ganoderma lucidum Polysaccharides: Immunomodulation and Potential Anti-Tumor Activities
Xu, Zengtao
Chen, Xiuping
Zhong, Zhangfeng
Chen, Lidian
Wang, Yitao
AMERICAN JOURNAL OF CHINESE MEDICINE, 2011, 39 (01): : 15 - 27
[26] A novel metabolic therapeutic that harnesses the anti-tumor immune response
Rivadeneira, Dayana
Scharping, Nicole
Delgoffe, Greg
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[27] Telomerase in anti-tumor response
Batinac, Tanja
Zamolo, Gordana
Hadzisejdic, Ita
MEDICAL HYPOTHESES, 2007, 68 (01) : 128 - 130
[28] Anti-tumor activity of C-raf antisense—correction
Brett P. Monia
Nature Medicine, 1999, 5 : 127 - 127
[29] PHI-501, a novel pan-RAF/DDRs dual kinase inhibitor, overcomes BRAF or MEK inhibitor resistance in melanoma
Kim, Sue Min
Park, Jung Hee
Nam, Ky-Youb
Han, June H-J
Kim, Kyu-Tae
Yoon, Jeong Hyeok
Sengupta, Sandip
Sim, Taebo
Shin, Sang Joon
CANCER RESEARCH, 2023, 83 (07)
[30] A benzoxazole compound as a novel MEK inhibitor for the treatment of RAS/RAF mutant cancer
Cheng, Ying
Wang, Xingkai
Xia, Xiangying
Zhang, Wei
Tian, Hongqi
INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (02) : 586 - 596

← 1 2 3 4 5 →